Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (364)
  2. Journal Article (358)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (790)
  2. Department of Medicine (790)
  3. Gastrointestinal Oncology Service (790)
  4. Solid Tumor Oncology Division (790)
  5. Epidemiology and Biostatistics (178)
  6. Surgery (168)

More Groups

People
  1. Ghassan Abou-Alfa (156)
  2. Kenneth Yu (121)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (94)
  6. William Jarnagin (84)

More People

Years
  1. 2025 (38)
  2. 2024 (75)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (294)
  2. Annals of Oncology (48)
  3. Cancer (27)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (308)
  2. Oxford University Press (71)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (42)
  6. American Association for Cancer Research (40)

More Publishers

Results (790)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • POLO: Efficacy and health-related quality of life (HRQOL) with maintenance olaparib following first-line platinum-based chemotherapy (PBC) in patients (PTS) with a germline BRCA mutation and metastatic pancreatic cancer (MPC)
    Meeting Abstract

    Reinacher-Schick, A. C.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Mercade, T. M.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Oh, D. Y.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • The role of PARP inhibitors in germline BRCA-associated pancreatic ductal adenocarcinoma
    Review

    Moffat, G. T.; O’Reilly, E. M.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • A mixed methods analysis of patients’ advance care planning values in outpatient oncology: Person-centered oncologic care and choices (P-COCC)
    Journal Article

    Agarwal, R.; Shuk, E.; Romano, D.; Genoff, M.; Li, Y.; O’Reilly, E. M.; Breitbart, W.; Volandes, A. E.; Epstein, A. S.
    Supportive Care in Cancer (2020)

    Fulltext@MSK | Save
  • Neoadjuvant treatment in patients with resectable and borderline resectable pancreatic cancer
    Review

    Janssen, Q. P.; O'Reilly, E. M.; van Eijck, C. H. J.; Koerkamp, B. G.
    Frontiers in Oncology (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • How I treat metastatic pancreatic cancer with chemotherapy
    Book Section

    Krantz, B. A.; O'Reilly, E. M.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • How I treat metastatic pancreatic cancer with emerging therapies
    Book Section

    Krantz, B. A.; O'Reilly, E. M.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • Prognostic value of the Memorial Sloan Kettering (MSK) prognostic score (MPS) in pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Lebenthal, J.; Zheng, J. T.; Glare, P. A.; O'Reilly, E. M.; Epstein, A. S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save